Aminoglycoside ototoxicity

Drugs of Today

Volumn 39, Issue 4, 2003, Pages 277-285

  Bates, Duane E ^a  

^a FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BUMETANIDE; CHLOROQUINE; CISPLATIN; CLARITHROMYCIN; DIZOCILPINE; DOXYCYCLINE; ERYTHROMYCIN; ETACRYNIC ACID; FUROSEMIDE; GENTAMICIN; IFENPRODIL; IRON CHELATING AGENT; KANAMYCIN; MINOCYCLINE; NEOMYCIN; NETILMICIN; NONSTEROID ANTIINFLAMMATORY AGENT; PAROMOMYCIN; QUININE; SALICYLIC ACID DERIVATIVE; SISOMICIN; STREPTOMYCIN; THIOCTIC ACID; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

AMINO ACID SUBSTITUTION; CLINICAL TRIAL; DISEASE PREDISPOSITION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; HEARING LOSS; HISTOPATHOLOGY; HUMAN; INCIDENCE; INNER EAR DISEASE; MUTATIONAL ANALYSIS; NONHUMAN; OTOTOXICITY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; VESTIBULAR DISORDER;

ADMINISTRATION, TOPICAL; AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; COCHLEA; DRUG ADMINISTRATION SCHEDULE; HEARING LOSS; HUMANS; RISK FACTORS; VESTIBULE;

EID: 0038633534     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2003.39.4.799404     Document Type: Review

References (72)

1. Gilbert, D.N. Aminoglycosides. In: Mandell, G.L., Bennett, J.E., Dolin, R. (Eds.). Principles and Practice of Infectious Diseases, 5th ed. Churchill Livingstone, Philadelphia, PN 2000, 307-36.
2. McEvoy, G.K. (Ed.). American Hospital Formulary Service Drug Information. American Society of Health System Pharmacists, Bethesda MD 2001, 67-73.
3. Brummett, R.E. Drug induced ototoxicity. Drugs 1980, 19: 412-28.
4. Brummett, R.E., Fox, K.E. Aminoglycoside induced hearing loss in humans. Antimicrob Agents Chemother 1989, 33: 797-800.
5. Forge, A., Schacht, J. Aminoglycoside antibiotics. Audiol Neurootol 2000, 5: 3-22.
6. Ferriols-Lisart, R., Alos-Alminana, M. Effectiveness and safety of once daily aminoglycosides: A meta-analysis. Am J Health-Syst Pharm 1996, 53: 1141-50.
7. Ali, M.Z., Goetz, M.B. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997, 24: 796-809.
8. Gatell, J.M., Ferran, F., Araujo, V. et al. Univariate and multivariate analyses or risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother 1987, 31: 1383-7.
9. Barza, M., Ioannidis, J.P.A., Cappelleri, J.C., Lau, J. Single or multiple doses of aminoglycosides: A meta-analysis. BMJ 1996, 312: 338-45.
10. Hatala, R., Dinh, T., Cook, D.J. Once daily aminoglycoside dosing in immunocompetent adults: A meta-anaylsis. Ann Intern Med 1996, 124: 717-25.
11. Bailey, T.C., Little, J.R., Littenberg, B., Reichley, Dunagan, C. A meta-analysis of extended dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997, 24: 786-95.
12. Munckhof, W.J., Grayson, M.L., Turnidge, J.D. A meta-analysis on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 1996, 37: 645-63.
13. Barclay, M.L., Kirkpatrick, C.M.J., Begg, E.J. Once daily aminoglycoside therapy is it less toxic than multiple daily doses and how should it be monitored. Clin Pharmacokinet 1999, 36: 89-98.
14. Galloe, A.M., Graudal, N., Christensen, H.R., Kampmann, J.P. Aminoglycoside: Single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol 1995, 48: 39-43.
15. Govaerts, P.J., Van De Heyning, P.H., Jorens, G., Marquet, J., De Broe, M.E. Aminoglycoside induced ototoxicity. Toxicol Lett 1990, 53: 227-51.
16. Garrison, M.W., Zaske, D.E., Rotschafer, J.C. Aminoglycosides: Another perspective. DICP Ann Pharmacother 1990, 24: 267-72.
17. Nicolau, D.P., Freeman, C.D., Belliveau, P.P., Nightingale, C.H., Ross, J.W., Quintiliani, R. Experience with once daily aminoglycoside program administered to 2, 184 adult patients. Antimicrob Agents Chemother 1995, 39: 650-5.
18. Rybak, M.J., Abate, B.J., Kang, S.L., Ruffing, M.J., Lerner, S.A., Drusano, G.L. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 1999, 43: 1549-55.
19. Zheng, Y., Schachern, P.A., Sone, M., Papapella, M.M. Aminoglycoside ototoxicity. Otolog Neurotol 2001, 22: 266-8.
20. Hinojosa, R., Nelson, E.G., Lerner, S.A., Redleaf, M.I., Schramm, D.R. Aminoglycoside ototoxicity: A human temporal bone study. Laryngoscope 2001, 111: 1797-1805.
21. Thomas, J., Marion, M.S., Hinojosa, R. Neomycin ototoxicity. Am J Otolaryngol 1992, 13: 54-5.
22. Sone, M., Schachern, P.A., Paparella, M.M. Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity. Hear Res 1998, 115: 217-23.
23. Tsuji, K., Rauch, S.D., Wall, C., Velazquez-Villasenor, L., Glynn, R.J., Merchant, S.N. Temporal bone studies of the human vestibular system: Aminoglycoside ototoxicity. Ann Otol Rhinol Laryngol 2000, 109: 20-5.
24. Schacht, J. Biochemical basis of aminoglycoside ototoxicity. Otolaryngol Clin N Am 1993, 26: 845-56.
25. Wu, W.J., Sha, S.H., Schacht, J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol 2002, 7: 171-4.
26. Schacht, J. Biochemistry and pharmacology of aminoglycoside induced hearing loss. Acta Physiol Pharmacol Ther Latinoam 1999, 49: 251-6.
27. Basile, A.S., Huang, J.M., Xie, C., Webster, D., Berlin, C., Skolnick, P. N-methyl-D aspartate antagonists limit aminoglycoside antibiotic induced hearing loss. Nat Med 1996, 2: 1338-43.
28. Sha, S.H., Schacht, J. Are aminoglycoside antibiotics excitotoxic? Neuroreport 1998, 9: 3893-5.
29. Tran Ba Huy, P., Bernard, P., Schacht, J. Kinetics of gentamicin uptake and release in the rat. J Clin Invest 1986, 77: 1492-1500.
30. Henley, C.M., Schacht, J. Pharmacokinetics of aminoglycoside antibiotics in blood, inner ear fluids and tissues and their relationship to ototoxicity. Audiology 1988, 27: 137-46.
31. Huang, M.Y., Schacht, J. Drug induced ototoxicity pathogenesis and prevention. Med Toxicol Adverse Drug Exp 1989, 4: 452-67.
32. Fischel-Ghodsian, N., Prezant, T.R., Chaltraw, W.E. et al. Mitochondrial gene mutation is a significant risk factor in aminoglycoside ototoxicity. Am J Otolaryngol 1997, 18: 173-8.
33. Fischel-Ghodsian, N. Genetic factors in aminoglycoside toxicity. Ann NY Acad Sci 1999, 884: 99-109.
34. Fischel-Ghodsian, N., Prezant, T.R., Bu, X., Oztas, S. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am J Otolaryngol 1993, 14: 399-403.
35. Gardner, J.C., Goliath, R., Viljoen, D. et al. Familial streptomycin ototoxicity in a south african family: A mitochondrial disorder. J Med Genet 1997, 34: 904-6.
36. Shohat, M., Fischel-Ghodsian, N., Legum, C., Halpren, G.J. Aminoglycoside induced deafness with the mitochondrial DNA mutation A 1555G. Am J Otolaryngol 1999, 20: 64-7.
37. Casano, R., Johnson, D.F., Bykhovskaya, Y., Torricelli, F., Bigozzi, M., Fischel-Ghodsian, N. Inherited susceptibility to aminoglycoside ototoxicity: Genetic heterogenicity and clinical implications. Am J Otolaryngol 1999, 20: 151-6.
38. Black, F.O., Pesznecker, S.C. Vestibular ototoxicity: Clinical considerations. Otolaryngol Clin N Am 1993, 26: 713-36.
39. Moore, R.D., Smith, C.R., Lietman, P.S. Risk factors for the development of auditory toxicity in patient receiving aminoglycosides. J Infect Dis 1984, 149: 23-30.
40. Manian, F.A., Stone, Alford, R.H. Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis 1990, 12: 236-49.
41. Seligmann, H., Podoshin, L., Ben-David, J., Fradis, M., Goldsher. Drug induced tinnitus and other hearing disorders. Drug Safety 1996, 14: 198-212.
42. Tange, R.A. Ototoxicity. Adverse Drug React Toxicol Rev 1998, 17: 75-89.
43. McCormack, J.P., Jewesson, P.J. A critical reevaluation of the therapeutic range of aminoglycosides. Clin Infect Dis 1992, 14: 320-39.
44. Paterson, D.L., Robson, J., Wagener, M.M. Risk factors for toxicity in elderly patients given aminoglycosides once daily. J Gen Intern Med 1998, 13: 735-9.
45. Schwade, N.D. Pharmacology in audiology practice. In: Roeser, R.J., Valente, M., Hosford-Dunn, H. (Eds.). Audiology Diagnosis. Thieme Medical Publishers, New York, NY 2000; 139-51.
46. Schacht, J. Aminoglycoside ototoxicity: Prevention in sight? Otolaryngol Head Neck Surg 1998, 118: 674-7.
47. El Bakri, F., Pallett, A., Smith, A.G., Duncombe, A.S. Ototoxicity induced by once daily gentamicin. Lancet 1998, 351: 1407-8.
48. Singer, C., Smith, C., Krieff, D. Once daily aminoglycoside therapy: Potential ototoxicity. Antimicrob Agents Chemother 1996, 40: 2209-11.
49. Warkentin, D., Ippoliti, C., Bruton, J., Van Besien, K., Champlin, R. Toxicity of single daily dose gentamicin in stem cell transplantation. Bone Marrow Transplant 1999, 24: 57-61.
50. Bates, D.E., Beaumont, S.J., Baylis, B.W. Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother 2002, 36: 446-51.
51. Bath, A.P., Walsh, R.M., Bance, M.L., Rutka, J.A. Ototoxicity of topical gentamicin preparations. Laryngoscope 1999, 109: 1088-93.
52. Wong, D.L.H., Rutka, J.A. Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations? Otolaryngol Head Neck Surg 1997, 116: 404-10.
53. Stockwell, M. Gentamicin ear drops and ototoxicity: Update. CMAJ 2001, 164: 93-4.
54. Marais, J. Rutka, J.A. Ototoxicity and topical eardrops. Clin Otolaryngol 1998, 23: 360-7.
55. Longridge, N.S. Topical gentamicin vestibular toxicity. J Otolaryngol 1994, 23: 444-6.
56. Hui, Y., Park, A., Crysdale, W.S., Forte, V. Ototoxicity from ototopical aminoglycosides. J Otolaryngol 1997, 26: 53-6.
57. Schacht, J. Antioxidant therapy attenuates aminoglycoside induced hearing loss. Ann NY Acad Sci 1999, 884: 125-30.
58. Priuska, E.M., Schacht, J. Mechanism and prevention of aminoglycoside ototoxicity: Outer hair cell as targets and tools. Ear Nose Throat J 1997, 76: 164-71.
59. Hoffman, D.W., Whitworth, C.A., Jones-King, K.L., Rybak, L.P. Potentiation of ototoxicity by glutathione depletion. Ann Otol Rhinol Laryngol 1988, 97: 36-41.
60. Hoffman, D.W., Whitworth, C.A., Jones, K.L., Rybak, L.P. Nutritional status, glutathione levels, and ototoxicity of loop diuretics and aminoglycoside antibiotics. Hear Res 1987, 31: 217-22.
61. Lautermann, J., McLaren, J., Schacht, J. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res 1995, 86: 15-24.
62. Conlon, B.J., Aran, J.M., Erre, J.P., Smith, D.W. Attenuation of aminoglycoside induced cochlear damage with the metabolic antioxidant α-lipoic acid. Hear Res 1999, 128: 40-4.
63. Sha, S.H., Schacht, J. Antioxidants attenuate gentamicin induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res 2000, 142: 34-40.
64. Song, B.B., Sha, S.H., Schacht, J. Iron chelators protect from aminoglycoside induced cochleo and vestibulo toxicity. Free Radic Biol Med 1998, 25: 189-95.
65. Conlon, B.J., Perry, B.P., Smith, D.W. Attenuation of neomycin ototoxicity by iron chelation. Laryngoscope 1998, 108: 284-7.
66. Song, B.B., Anderson Schacht, J. Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo. J Pharmacol Exp Ther 1997, 282: 369-77.
67. Song, B.B., Schacht, J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res 1996, 94: 87-93.
68. Sha, S.H., Schacht, J. Salicylate attenuates gentamicin induced ototoxicity. Lab Invest 1999, 79: 807-13.
69. Salicylates. In: Kent, D.A., Willis, G.A. (Eds.). Poison Management Manual, 4th ed. British Columbia Drug and Poison Information Centre 1997; 542-9.
70. Porter, J.B. A risk benefit assessment of iron chelation therapy. Drug Safety 1997, 17: 407-21.
71. Kanno, H., Yamanobe, S., Rybak, L.P. The ototoxicity of deferoxamine mesylate. Am J Otolaryngol 1995, 16: 148-52.
72. Ryals, B., Westbrook, W., Schacht, J. Morphological evidence of ototoxicity of the iron chelator deferoxamine. Hear Res 1997, 112: 44-8.